| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |